scorecardresearch
Sunday, July 27, 2025
TopicCovaxin

Topic: Covaxin

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech

Drug regulator DCGI’s approval to Bharat Biotech’s Covaxin for emergency use is subject to certain conditions detailed in the ‘permission form’.

Congress questions why Bharat Biotech’s Covaxin was cleared without completing phase-3 trials

Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Strict follow-up, informed consent from recipients — conditions set for cleared Covid vaccines

India has given conditional emergency-use licence to two Covid vaccines — the Oxford-AstraZeneca candidate Covishield, and Bharat Biotech’s Covaxin.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

Everything you need to know about Covaxin, India’s controversial Covid vaccine candidate

Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.

Covid protection with placebo too? Bharat Biotech’s pitch for volunteers raises concerns

Bharat Biotech has asked Covaxin trial sites to offer Covid protection as an incentive to draw volunteers. Experts say it is unethical.

Covaxin Phase 2 trials find Covid vaccine safe, no serious adverse events reported

Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.

Covaxin Phase I trial results show vaccine is safe, generates immune response

In a preprint paper, researchers from Bharat Biotech, ICMR, AIIMS have reported the results of the trial on 375 participants. 

On Camera

Maharashtra’s language war reaches West Bengal. Actor Prosenjit Chatterjee is the first victim

While the language war in other states is targeting those who can't speak the local language, in Bengal, even those whose mother tongue is Bengali have to constantly prove their Bengali-ness.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

DRDO successfully tests latest version of UAV-launched precision missile, ULPGM-V3

Capable of being fired in plain and high-altitude areas, it has day-and-night capability and two-way data link to support post-launch target, aim-point update.

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.